Literature DB >> 32586930

Stop, think SCORTCH: rethinking the traditional 'TORCH' screen in an era of re-emerging syphilis.

Justin Penner1, Hayley Hernstadt2, James Edward Burns3, Paul Randell4, Hermione Lyall2.   

Abstract

BACKGROUND: The epidemiology of congenital infections is ever changing, with a recent resurgence in syphilis infection rates seen in the UK. Identification of congenital infection is often delayed; early recognition and management of congenital infections is important. Testing modalities and investigations are often limited, leading to missed diagnostic opportunities.
METHODS: The SCORTCH (syphilis, cytomegalovirus (CMV), 'other', rubella, toxoplasmosis, chickenpox, herpes simplex virus (HSV) and blood-borne viruses) acronym increases the awareness of clinicians to the increased risk of congenital syphilis, while considering other infectious aetiologies including: zika, malaria, chagas disease, parvovirus, enterovirus, HIV, hepatitis B and C, and human T-lymphotropic virus 1, in addition to the classic congenital infections recognised in the 'TORCH screen' (toxoplasmosis, 'other', rubella, CMV, HSV). The SCORTCH diagnostic approach describes common signs present in infants with congenital infection, details serological testing for mother and infant and important direct diagnostics of the infant. Direct diagnostic investigations include: radiology, ophthalmology, audiology, microbiological and PCR testing for both the infant and placental tissue, the latter also warrants histopathology.
CONCLUSION: The traditional 'TORCH screen' focuses on serology-specific investigations, often omits important direct diagnostic testing of the infant, and fails to consider emerging and re-emerging congenital infections. In recognition of syphilis as a re-emerging pathogen and the overlapping clinical presentations of various infectious aetiologies, we advocate for a broader outlook using the SCORTCH diagnostic approach. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  congenital abnorm; infectious diseases; microbiology; neonatology; virology

Year:  2020        PMID: 32586930     DOI: 10.1136/archdischild-2020-318841

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

1.  Short- and mid-term multidisciplinary outcomes of newborns exposed to SARS-CoV-2 in utero or during the perinatal period: preliminary findings.

Authors:  Danilo Buonsenso; Simonetta Costa; Lucia Giordano; Francessca Priolo; Arianna Turriziani Colonna; Sofia Morini; Martina Sbarbati; Davide Pata; Anna Acampora; Guido Conti; Fabrizio Crudo; Alessandro Cantiani; Bianca Maria Martina; Giulia Maria Amorelli; Lorenzo Orazi; Maria Petrianni; Daniela Ricci; Antonio Lanzone; Maurizio Sanguinetti; Paola Cattani; Michela Sali; Domenico Romeo; Giuseppe Zampino; Giovanni Vento; Piero Valentini
Journal:  Eur J Pediatr       Date:  2022-01-11       Impact factor: 3.860

2.  Psychological Impact of the COVID-19 Pandemic on Pregnant Women.

Authors:  Danilo Buonsenso; Walter Malorni; Arianna Turriziani Colonna; Sofia Morini; Martina Sbarbati; Alessandro Solipaca; Antonio Di Mauro; Brigida Carducci; Antonio Lanzone; Umberto Moscato; Simonetta Costa; Giovanni Vento; Piero Valentini
Journal:  Front Pediatr       Date:  2022-04-12       Impact factor: 3.569

Review 3.  From Fetal to Neonatal Neuroimaging in TORCH Infections: A Pictorial Review.

Authors:  Giulia Lucignani; Alessia Guarnera; Maria Camilla Rossi-Espagnet; Giulia Moltoni; Amanda Antonelli; Lorenzo Figà Talamanca; Chiara Carducci; Francesca Ippolita Calo Carducci; Antonio Napolitano; Carlo Gandolfo; Francesca Campi; Cinzia Auriti; Cecilia Parazzini; Daniela Longo
Journal:  Children (Basel)       Date:  2022-08-11

4.  Auditory and Language Development Assessment of Newborns Aged One to Four Years Exposed to Gestational Zika Virus Infection: A Case Series.

Authors:  Liora Gonik; Amanda Tupinambá da Fonseca Oliveira; Paula Silva de Carvalho Chagas; Jaqueline da Silva Frônio
Journal:  Int J Environ Res Public Health       Date:  2021-06-18       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.